SmiLe participates in Expo 2020 in Dubai as part of Swecare’s official Life Science delegation. During the Health & Wellness week, SmiLe will showcase the breadth and depth of early Swedish life science innovation and participate in discussions on global healthcare challenges.
SmiLe’s participation at the Health and Wellness Week kicks off on January 31st as CEO Ebba Fåhraeus joins a panel discussion hosted by the India-Sweden Healthcare Innovation Centre. In this panel titled “Role of Technology and Innovation in the new age healthcare delivery” experts from both public and private sector in India and Sweden will share experiences and discuss possible ways forward to strengthen the healthcare systems to make them more resilient.
On February 1-2, SmiLe will participate in the virtual programme hosted by Swecare, The Ministry of Health and Social Affairs and Vision Zero Cancer in the Swedish Pavilion, and showcase a number of innovative solutions developed by SmiLe companies. The programme, dedicated to discussing solutions to global healthcare challenges, consists of a ministerial roundtable and presentations and discussions with speakers and experts from Sweden, the Gulf region and other partner countries as well as WHO.
”It is a great honour to represent SmiLe as part of the Swedish Life Science delegation. I am extremely proud of all the SmiLe companies we are showcasing during this event, they represent the very best of Swedish life science innovation,” says Ebba Fåhraeus, CEO of SmiLe Incubator
On February 2nd, there will be a short video presentation by Kristina Masson from Smile company Acrivon – “Patient selection test to match therapeutics with patients” – as part of the program focusing on the elimination of cancer as a life-threatening disease for future generations.
Other SmiLe companies showcasing Swedish life science innovation during Expo 2020 are:
TIGERQ has redesigned the fundamentals of sequencing analysis with a patented solution to newfound sequencing accuracy problems – that can save lives, time, and money across hospitals, pharma industry, and academia
Medow has developed the IV-bracelet, a medical device designed to keep the tubing in place during intravenous treatments, such as infusion or dialysis, so that the patient can move around safely without discomfort or complications, decreasing the nurses' workload.
Medilevel connects patients and caregivers via modern digital tools and creates a resource efficient, safe and secure medicine titration.
Xinnate uses nature’s own host defense through its lead drug candidate BioC to combat infection and inflammation in wounds and other topical indications.
GPX MEDICAL has developed NEOLA - as a non-invasive medical device for continuous monitoring of the lungs of preterm born infants with an instant detection of complications.
Acrivon specializes in accelerated drug development in oncology, using a unique, predictive phospho-proteomic approach. Their proprietary technology platform identifies drug-tailored biomarker signatures for patient responder identification, to enable increased efficacy and successful clinical outcomes.
Virtual showroom: As an official partner to the Swedish Expo 2020 organization, SmiLe also participates with a virtual showroom in the Swedish pavilion will be open throughout the exhibition: https://expoupdate.newstag.se/partners/smile-incubator/
For more information: Ebba Fåhraeus, CEO, SmiLe Incubator, tel +46 73 4000433